A phase II study of pembrolizumab and eribulin in patients with HR-positive/HER2-negative metastatic breast cancer previously treated with anthracyclines and taxanes (KELLY study)


Por: Perez-Garcia, J, Llombart-Cussac, A, Holgado, E, Curigliano, G, Miranda, E, Alonso-Romero, J, Bermejo, B, Calvo, L, Caranana, V, Sanchez, S, Cortes, M, Vazquez, R, Prat, A, Borrego, M, Sampayo, M, Segui, M, Soberino, J, Malfettone, A, Schmid, P and Cortes, J

Publicada: 1 feb 2020
Resumen:


Filiaciones:
Perez-Garcia, J:
 QuironSalud Grp, Inst Oncol, IOB, Barcelona, Spain

 Med Scientia Innovat Res MedSIR, Randolph, NJ USA

 Med Scientia Innovat Res MedSIR, Barcelona, Spain

:
 Med Scientia Innovat Res MedSIR, Randolph, NJ USA

 Med Scientia Innovat Res MedSIR, Barcelona, Spain

 FISABIO, Hosp Arnau Vilanova, Valencia, Spain

Holgado, E:
 Med Scientia Innovat Res MedSIR, Randolph, NJ USA

 Med Scientia Innovat Res MedSIR, Barcelona, Spain

 Hosp Univ Ramon & Cajal, Madrid, Spain

Curigliano, G:
 Univ Milan, European Inst Oncol IRCCS, Milan, Italy

Alonso-Romero, J:
 Univ Virgen Arrixaca, Hosp Clin, Murcia, Spain

Bermejo, B:
 Hosp Clin Valencia, Valencia, Spain

Calvo, L:
 Chuac, La Coruna, Spain

:
 Hosp Arnau Vilanova, Valencia, Spain

Sanchez, S:
 Complejo Hosp Navarra, Pamplona, Spain

Cortes, M:
 Hosp Univ Ramon & Cajal, Madrid, Spain

Vazquez, R:
 MD Anderson Canc Ctr, Madrid, Spain

Prat, A:
 Hosp Clin Barcelona, Barcelona, Spain

 Hosp Univ Virgen Rocio, Seville, Spain

Sampayo, M:
 Med Scientia Innovat Res MedSIR, Randolph, NJ USA

 Med Scientia Innovat Res MedSIR, Barcelona, Spain

Segui, M:
 Corp Sanit Sanit Parc Tauli, Sabadell, Spain

Soberino, J:
 QuironSalud Grp, Inst Oncol, IOB, Barcelona, Spain

Schmid, P:
 Queen Mary Univ London, Barts Canc Inst, London, England

Cortes, J:
 Med Scientia Innovat Res MedSIR, Randolph, NJ USA

 Med Scientia Innovat Res MedSIR, Barcelona, Spain

 QuironSalud Grp, Inst Oncol, IOB, Madrid, Spain

 VHIO, Barcelona, Spain
ISSN: 00085472





CANCER RESEARCH
Editorial
American Association for Cancer Research, 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA, Estados Unidos America
Tipo de documento: Meeting Abstract
Volumen: 80 Número: 4
Páginas:
WOS Id: 000527012501377

MÉTRICAS